In addition, in line with our results, Inoue et al. recently showed that an overall increase of circulating CALR levels in patients with advanced lung cancer treated with platinum-based combination or single-agent chemotherapy tended to be associated with a clinical tumor response [44]. The gene discussed is CALR; the disease is lung cancer.